Nemaura Medical Inc.
Index- P/E- EPS (ttm)-0.54 Insider Own49.07% Shs Outstand24.10M Perf Week20.55%
Market Cap24.43M Forward P/E- EPS next Y-0.54 Insider Trans0.00% Shs Float9.85M Perf Month-10.20%
Income-13.10M PEG- EPS next Q-0.16 Inst Own3.50% Short Float / Ratio0.41% / 0.24 Perf Quarter-49.57%
Sales0.40M P/S61.07 EPS this Y-111.40% Inst Trans-1.42% Short Interest0.04M Perf Half Y-47.31%
Book/sh-0.41 P/B- EPS next Y5.30% ROA-75.50% Target Price8.67 Perf Year-78.43%
Cash/sh0.26 P/C3.35 EPS next 5Y- ROE243.20% 52W Range0.70 - 4.58 Perf YTD-48.75%
Dividend- P/FCF- EPS past 5Y-51.00% ROI-36.70% 52W High-80.77% Beta-0.02
Dividend %- Quick Ratio0.60 Sales past 5Y- Gross Margin37.80% 52W Low25.71% ATR0.09
Employees32 Current Ratio0.80 Sales Q/Q-98.40% Oper. Margin- RSI (14)46.18 Volatility7.78% 8.35%
OptionableYes Debt/Eq- EPS Q/Q51.60% Profit Margin- Rel Volume0.07 Prev Close0.90
ShortableYes LT Debt/Eq- EarningsFeb 24 BMO Payout- Avg Volume169.11K Price0.88
Recom2.00 SMA205.22% SMA50-27.05% SMA200-53.76% Volume12,070 Change-1.92%
Mar-29-22Initiated H.C. Wainwright Buy $12
Mar-21-23 08:00AM
Mar-15-23 08:00AM
Mar-09-23 04:57PM
Feb-24-23 10:15AM
08:15AM Loading…
Feb-16-23 08:15AM
Jan-31-23 01:50PM
Jan-27-23 08:20AM
Jan-26-23 09:57AM
Jan-24-23 12:27PM
Jan-17-23 10:00AM
Jan-11-23 08:00AM
08:30AM Loading…
Dec-05-22 08:30AM
Dec-01-22 08:15AM
Nov-29-22 08:00AM
Nov-15-22 09:45AM
Nov-11-22 08:00AM
Nov-04-22 08:00AM
Oct-12-22 11:00AM
Oct-04-22 08:00AM
Sep-27-22 09:05AM
Sep-06-22 08:30AM
Aug-26-22 09:03AM
Aug-15-22 09:45AM
08:17AM Loading…
Aug-08-22 08:17AM
Jul-21-22 08:00AM
Jun-30-22 08:00AM
Jun-02-22 03:46PM
May-23-22 06:30AM
May-19-22 08:00AM
May-17-22 08:00AM
May-03-22 08:00AM
Apr-27-22 09:00AM
Apr-25-22 08:30AM
Mar-24-22 04:24PM
Feb-28-22 08:00AM
Feb-14-22 08:00AM
Jan-13-22 08:30AM
Jan-10-22 08:00AM
Jan-07-22 08:00AM
Dec-07-21 09:00AM
Nov-30-21 08:00AM
Nov-15-21 09:30AM
Nov-03-21 06:51PM
Oct-25-21 01:02PM
Oct-19-21 12:45PM
Oct-06-21 12:05PM
Oct-05-21 08:00AM
Sep-29-21 11:17AM
Sep-28-21 01:50PM
Sep-27-21 08:00AM
Sep-24-21 08:30AM
Sep-22-21 08:30AM
Sep-21-21 08:30AM
Sep-20-21 10:51AM
Sep-17-21 09:05AM
Sep-01-21 08:00AM
Aug-16-21 08:30AM
Jul-26-21 07:08AM
Jul-12-21 08:28AM
Jul-08-21 11:20AM
Jun-30-21 09:15AM
Jun-21-21 08:01AM
Jun-01-21 08:05AM
May-27-21 07:15PM
May-26-21 08:05AM
May-06-21 08:00AM
May-05-21 08:00AM
May-04-21 04:10PM
Apr-29-21 08:04AM
Apr-21-21 08:10AM
Apr-15-21 08:07AM
Apr-13-21 08:05AM
Mar-25-21 08:10AM
Mar-11-21 08:00AM
Mar-10-21 08:00AM
Mar-04-21 08:00AM
Mar-02-21 08:00AM
Feb-16-21 08:30AM
Feb-11-21 08:45AM
Feb-08-21 02:57AM
Feb-04-21 08:30AM
Feb-01-21 08:00AM
Jan-25-21 05:11AM
Jan-11-21 08:00AM
Dec-17-20 08:00AM
Dec-11-20 09:00AM
Nov-17-20 08:00AM
Nov-16-20 08:00AM
Oct-22-20 08:00AM
Sep-21-20 08:00AM
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.